Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)

Table 1 The clinical features of ESCC patients for mass spectrometry

No.	Gender	Age	Organ/anatomic site	Grade	TNM
1	Male	69	Mid-thoracic esophagus	II	T2N0MO
2	Male	61	esophagus	I	T1N0M0
3	Male	59	Middle-lower esophagus	II	T1N0M0
4	Male	52	Mid-thoracic esophagus	III	T3N0M0
5	Male	64	Middle segment of esophagus	II	T2N1M1

ISSN: 1559-0275